Metal Oxide Semiconductor Nanoparticles Open the Door to New Medical Innovations

Technology available for licensing: novel nanometer-sized metal oxide semiconductors that allow targeting, initiating and control of in vitro and in vivo chemical reactions in biological molecules, such as DNA, proteins, and antibodies.

Allows for targeting, initiation and control of in vitro and in vivo chemical reactions in biological molecules